Rentokil Initial plc (LON:RTO – Get Free Report) insider Brian Baldwin acquired 7,500,000 shares of the stock in a transaction that occurred on Wednesday, December 11th. The stock was purchased at an average cost of GBX 413 ($5.21) per share, with a total value of £30,975,000 ($39,095,039.76).
Rentokil Initial Stock Up 3.7 %
Shares of Rentokil Initial stock opened at GBX 413.51 ($5.22) on Friday. The company has a debt-to-equity ratio of 116.58, a current ratio of 1.04 and a quick ratio of 1.76. Rentokil Initial plc has a 1-year low of GBX 336.30 ($4.24) and a 1-year high of GBX 517.60 ($6.53). The business’s fifty day moving average price is GBX 386.78 and its two-hundred day moving average price is GBX 426.30. The company has a market capitalization of £10.38 billion, a P/E ratio of 2,584.44, a PEG ratio of 0.56 and a beta of 0.55.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft decreased their price target on shares of Rentokil Initial from GBX 550 ($6.94) to GBX 465 ($5.87) and set a “buy” rating for the company in a report on Thursday, September 12th.
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Stories
- Five stocks we like better than Rentokil Initial
- Health Care Stocks Explained: Why You Might Want to Invest
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Ride Out The Recession With These Dividend Kings
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Invest in the FAANG Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.